Latest CSL Behring Stories
MONMOUTH JUNCTION, N.J., Dec.
CSL Behring Continues Improving Patient Well-Being; Key Milestone Achieved in PROLONG-9FP, Company's Recombinant Factor IX Fusion Protein Development Program KING OF PRUSSIA,
Led by CSL Behring performance, the company focuses on sustainable business practices, strong results to provide patients with lifesaving, life-enhancing therapies around the world. KING OF
Designation Helps Improve Patient Access to Kcentra in the Inpatient Hospital Setting KING OF PRUSSIA, Pa., Dec.
FLORHAM PARK, N.J., Nov. 6, 2014 /PRNewswire/ -- Managed Health Care Associates, Inc.
Presentations focus on Hizentra flexible dosing regimens and push administration PRAGUE, Oct.
JNC is the Bleeding Disorders Community's Original Golf and Baseball Competition for Kids with Hemophilia and/or von Willebrand disease (VWD) and Their Families PHOENIX, Oct.
KING OF PRUSSIA, Pa., Oct.
bioCSL to take on expanded role in global influenza vaccine industry MELBOURNE, Australia, Oct.
CSL Plasma center openings are on the rise, as is the demand for plasma protein therapies for the treatment of rare and serious diseases. KING OF PRUSSIA, Pa., Oct.
- A volcanic mudflow.